ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 48 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 292,366 | $283,000 | 0.02% |
| Virtu Financial LLC | 204,870 | $199,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $139,000 | 0.02% |
| Founders Capital Management | 18,000 | $17,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $10,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $22,000 | 0.00% |
| Belvedere Trading LLC | 118,500 | $146,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $13,000 | 0.00% |
| Atom Investors LP | 56,492 | $55,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $21,000 | 0.00% |